These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 12470283)

  • 1. History and evolution of the pharmacophore concept in computer-aided drug design.
    Güner OF
    Curr Top Med Chem; 2002 Dec; 2(12):1321-32. PubMed ID: 12470283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacophore modeling in drug discovery and development: an overview.
    Khedkar SA; Malde AK; Coutinho EC; Srivastava S
    Med Chem; 2007 Mar; 3(2):187-97. PubMed ID: 17348856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the descriptor pharmacophores using variable selection QSAR: applications to database mining.
    Tropsha A; Zheng W
    Curr Pharm Des; 2001 May; 7(7):599-612. PubMed ID: 11375770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecule-pharmacophore superpositioning and pattern matching in computational drug design.
    Wolber G; Seidel T; Bendix F; Langer T
    Drug Discov Today; 2008 Jan; 13(1-2):23-9. PubMed ID: 18190860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pharmacophore Concept and Its Applications in Computer-Aided Drug Design.
    Seidel T; Schuetz DA; Garon A; Langer T
    Prog Chem Org Nat Prod; 2019; 110():99-141. PubMed ID: 31621012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting molecular interactions in silico: I. A guide to pharmacophore identification and its applications to drug design.
    Dror O; Shulman-Peleg A; Nussinov R; Wolfson HJ
    Curr Med Chem; 2004 Jan; 11(1):71-90. PubMed ID: 14754427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Drug Discovery and Design using Computer-aided Molecular Modeling.
    Singh K; Bhushan B; Singh B
    Curr Comput Aided Drug Des; 2024; 20(5):697-710. PubMed ID: 37711101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approach.
    Acharya C; Coop A; Polli JE; Mackerell AD
    Curr Comput Aided Drug Des; 2011 Mar; 7(1):10-22. PubMed ID: 20807187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: Descriptor Spaces for QSAR: Delving into the History of the Expanding Frontier.
    Basak SC; Mishra RK
    Curr Comput Aided Drug Des; 2017; 13(1):4-7. PubMed ID: 28222673
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacophore discovery--lessons learned.
    van Drie JH
    Curr Pharm Des; 2003; 9(20):1649-64. PubMed ID: 12871063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach.
    Kapetanovic IM
    Chem Biol Interact; 2008 Jan; 171(2):165-76. PubMed ID: 17229415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results.
    Dixon SL; Smondyrev AM; Knoll EH; Rao SN; Shaw DE; Friesner RA
    J Comput Aided Mol Des; 2006; 20(10-11):647-71. PubMed ID: 17124629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D-QSAR studies of some tetrasubstituted pyrazoles as COX-II inhibitors.
    Gupta GK; Kumar A
    Acta Pol Pharm; 2012; 69(4):763-72. PubMed ID: 22876620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of computer-aided drug design in modern drug discovery.
    Macalino SJ; Gosu V; Hong S; Choi S
    Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling.
    Ekins S; Mestres J; Testa B
    Br J Pharmacol; 2007 Sep; 152(1):9-20. PubMed ID: 17549047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel integrated framework and improved methodology of computer-aided drug design.
    Chen CY
    Curr Top Med Chem; 2013; 13(9):965-88. PubMed ID: 23651478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer-aided molecular design of highly potent HIV-1 RT inhibitors: 3D QSAR and molecular docking studies of efavirenz derivatives.
    Pungpo P; Saparpakorn P; Wolschann P; Hannongbua S
    SAR QSAR Environ Res; 2006 Aug; 17(4):353-70. PubMed ID: 16920659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the P2 and P3 ligand binding features for hepatitis C virus NS3 protease using some 3D QSAR techniques.
    Wei HY; Lu CS; Lin TH
    J Mol Graph Model; 2008 Apr; 26(7):1131-44. PubMed ID: 18024210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obituary: Toshio Fujita, QSAR pioneer.
    Akamatsu M; Oprea TI
    J Comput Aided Mol Des; 2017 Nov; 31(11):959-960. PubMed ID: 29119351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.